Reboxetine in depression. All the relevant data?

BMJ. 2010 Nov 16:341:c6487. doi: 10.1136/bmj.c6487.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antidepressive Agents / adverse effects
  • Antidepressive Agents / therapeutic use*
  • Depressive Disorder / drug therapy*
  • Humans
  • Morpholines / adverse effects
  • Morpholines / therapeutic use*
  • Reboxetine
  • Research Design
  • United States
  • United States Food and Drug Administration

Substances

  • Antidepressive Agents
  • Morpholines
  • Reboxetine